Acute hemodynamic changes induced by two beta-blocking agents, bunitrolol and propranolol, in patients with ischemic heart disease were studied.
Jpn. Heart J. May 1987 failure, especially that due to ischemic heart disease because of its lack of negative inotropic action and its ameliorating effect on ischemia at rest.
Additional
Indexing Words:
Bunitrolol Beta-blocking agent Ischemic heart disease Myocardial oxygen supply-demand balance ETA-BLOCKING agents are widely used for the treatment of ischemic heart disease and high blood pressure. However, untoward side effects of these agents such as heart failure, decreased coronary blood flow and increased myocardial oxygen demand due to dilatation of the left ventricle secondary to the negative inotropic and chronotropic actions of these drugs are sometimes observed.
Bunitrolol (Ko 1366, Boehringer Ingelheim, West Germany) is a very potent nonselective beta-blocking agent in terms of its ability to antagonize the chronotropic and inotropic effects of isoproterenol.1)-3) Furthermore, moderate but consistent positive chronotropic and inotropic effects, i.e. ISA, at relatively low dosage in the resting state3) and potent vasodilator action2), 3) have also been reported and these characteristics favor its use in the treatment of hypertension. The mechanisms of the vasodilator action have not been clarified as yet, but selective alpha-1 blocking activity4) and Ca++ antagonist activity5) have been reported recently.
Bunitrolol is also effective in exercise induced ischemia because of its strongly antagonistic activity to sympathetic nerve stimulation,6) but there have been very few actual hemodynamic assessments of this unique betablocking agent in patients with ischemic heart disease.7),8) The purpose of this study is to assess the actual hemodynamic effects of bunitrolol in patients with ischemic heart disease and to clarify the differences between those of propranolol.
PATIENTS AND METHODS
Using a protocol approved by the Human Subjects Ethical Committee of Tokyo University Hospital, we studied 17 patients with ischemic heart disease. All patients were referred for cardiac catheterization, including coronary cineangiography, because of chest pain and/or positive exercise tolerance test; a greater than 75% stenosis in at least one major coronary artery was documented in all cases. Administration of drugs such as nitrates, beta-blockers and Ca++ antagonists was stopped the morning before patients had catheters inserted. After informed consent had been obtained, patients 
RESULTS
Effects of bunitrolol (Table I) Following administration of bunitrolol, LVSP, LVEDP and T decreased significantly. HR, CI, DP, LV dp/dt, LV dp/dt/p and LV(-)dp/dt were not changed. SVR tended to decrease, though insignificantly. Effects of propranolol (Table II) HR, CI, DP, LV dp/dt, LV dp/dt/p and LV(-)dp/dt fell significantly in the propranolol group. There were no significant changes in LVSP and LVEDP. SVR and T increased significantly. end-diastolic pressure, which suggested dilatation of the left ventricle, indicated a worsened myocardial oxygen balance. Prolongation of the time constant T might be the summation of the effects of both direct negative inotropic action and worsened ischemia.
In conclusion, besides its effectiveness in exercise induced angina due to its potent negative chronotropic activity and hypotensive effects during exercise,6)-8) bunitrolol is effective in relieving ischemia at rest without any deterioration of cardiac contractility.
This beta-blocking agent is safe enough to be administered to the aged and/or to patients with overt heart failure.
